Sign in
CompletedNo phase

Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation

Key facts

Who runs it
Cochlear
Where
Lone Tree, United StatesSee the siteAlso in 2 other countries, 3 sites
Trial code
Status
Completed
People taking part
17 people enrolled
Started
14 Mar 2023
Ended
26 Feb 2025
Type of study
Interventional
Treatments tested
  • Categorical loudness scaling based fitting using the research fitting system.
  • Behavioural fitting using Custom Sound Suite (CSS 6.3) Software
Record updated
15 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Aged 18 years or older (no upper age limit)
  • Post-lingually deafened defined as severe or greater sensorineural hearing loss onset after the age of 2 years as reported by the subject
  • Unilaterally implanted with the CI600 Series (CI612, CI622, CI632) or CI500 series (CI512, CI522, CI532) cochlear implant
  • Fluent speaker in the language used to assess speech perception performance, as determined by the investigator
  • Willingness to participate in and comply with all requirements of the protocol
  • Willing and able to provide written informed consent

Who cannot take part

  • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation). -
  • Additional health factors, known to the investigator, that would prevent or restrict participation in the evaluations, including significant visual impairment and/or dexterity issues
  • Score below 3 on the screening subset of questions from the Mobile Device Proficiency Questionnaire
  • Subject who will be programmed with an acoustic component in the implanted ear
  • Pure tone average (average of unaided thresholds at 0.5, 1, 2 and 4 kHz) less than or equal to 30 dB HL and aided word score of more than 80% in the contralateral ear
  • Diagnosis of auditory neuropathy
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
  • Investigator site personnel directly affiliated with this study and/or their immediate families: immediate family is defined as a spouse, parent, child, or sibling
  • Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation

Where in United States

Also in 2 other countries, 3 sites

  • Cochlear AmericasLone Tree, United States

About the trial

What the trial wants to find out

This study aims to collect data in newly implanted cochlear implant-recipients to inform future development of fitting methods to optimally and efficiently program a cochlear implant.

The group in the trial

  • Participants receiving both Categorical Loudness Scaling Based Fitting and behavioural fitting.Treatment being tested

    Participants will receive a categorical loudness scaling based fitting (Interventional) and behavioural fitting with 4 weeks experience of both MAPS

    Treatment: Categorical loudness scaling based fitting using the research fitting system. and Behavioural fitting using Custom Sound Suite (CSS 6.3) Software

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Feasibility, Prospective, Within-subject, Interventional Study Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant in the First 3 Months Post-activation
Record updated
15 May 2026